SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (2022)10/13/2008 1:51:09 PM
From: Jibacoa  Respond to of 3722
 
SNTS is up 22.14% with volume almost 2x its ADV.

On Friday it announced that it started promotion of GLUMETZA (metformin hydrochloride extended release tablets).

(SNTS signed an agreement with DEPO back in Jul., granting SNTS exclusive rights to promote GLUMETZA in the U.S.)

bigcharts.marketwatch.com

The near resistance is now the Oct8 H at $1.93 <g>

Bernard